https://www.selleckchem.com/pr....oducts/epacadostat-i
In the 2017 ACC/AHA hypertension guidelines, a 10-year risk of more than 10% is considered for initiation of intensive blood pressure reduction. The current study aimed to determine which cut off limit of cardiovascular risk for starting intensive blood pressure reduction is beneficial. A Secondary Analysis of Systolic Blood Pressure Intervention Trial (SPRINT). Data from the SPRINT Trial was obtained from the NHLBI Data Repository Center. In the SPRINT, non-diabetic participants with SBP of ≥ 130 mmHg were randomly assig
Like
Comment
Share
